cdmo.directory
← Compare landing

Ajinomoto Bio-Pharma Services vs Aurigene Pharmaceutical Services Limited

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/ajibio-pharma/aurigeneservices

CategoryAjinomoto Bio-Pharma ServicesAurigene Pharmaceutical Services Limited
Listed sitecdmoboth
SummaryAjinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service.Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.
Services
  • Process Development
  • Small Molecule Development & Manufacturing
  • Biologics Development & Manufacturing
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Quality Control Testing
  • CMC Analytical Development
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • High-Throughput Screening
  • Computational & In-Silico Drug Discovery
  • Protein Engineering
Modalities
  • Small Molecule
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Gene Therapy
  • Peptide
  • Small Molecule
  • Biologics (Other)
  • Peptide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Belgium, Belgium, Belgium
  • United States, United States
  • Japan, Japan
  • India, India
  • Manufacturing - India, India
  • Manufacturing - UK, United Kingdom
  • Manufacturing - Mexico, Mexico
CertificationsData not yet provided.
  • FDA · Identifier: 16 US FDA-inspected cGMP facilities
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.